Yuta Asami

Yuta Asami

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKatsuhiro Tokutake
Katsuhiro Tokutake
MTMasaru Takeuchi
Masaru Takeuchi
SKShigeru Kurimoto
Shigeru Kurimoto
SSSota Saeki
Sota Saeki
YAYuta Asami
Yuta Asami
HHHitoshi Hirata
Hitoshi Hirata
Promising treatments for upper motor neuron disease are emerging in which motor function is restored by brain–computer interfaces and functional electrical stimulation. At present, such technologies and procedures are not applicable to lower motor neuron disease. We propose a novel therapeutic strategy for lower motor neuron disease and injury integrating neural stem cell transplantation with our new functional electrical stimulation control system. In a rat sciatic nerve transection model, we transplanted embryonic spinal neural stem cells into the distal stump of the peripheral nerve to reinnervate denervated muscle, and subsequently demonstrated that highly responsive limb movement similar to that of a healthy limb could be attained with a wirelessly powered two-channel neurostimulator that we developed. This unique technology, which can reinnervate and precisely move previously denervated muscles that were unresponsive to electrical stimulation, contributes to improving the condition of patients suffering from intractable diseases of paralysis and traumatic injury.

10 January 2023 in Injury
Verified
Journal Article
Closed access
KOKazuma Ohshima
Kazuma Ohshima
KTKatsuhiro Tokutake
Katsuhiro Tokutake
YTYasuhiko Takegami
Yasuhiko Takegami
YAYuta Asami
Yuta Asami
YMYuji Matsubara
Yuji Matsubara
SIShiro Imagama
Shiro Imagama

Verified
Journal Article
Open access
PDF file
SSSota Saeki
Sota Saeki
KTKatsuhiro Tokutake
Katsuhiro Tokutake
MTMasaki Takasu
Masaki Takasu
SKShigeru Kurimoto
Shigeru Kurimoto
YAYuta Asami
Yuta Asami
HHHitoshi Hirata
Hitoshi Hirata
Neural cell transplantation targeting peripheral nerves is a potential treatment regime for denervated muscle atrophy. This study aimed to develop a new therapeutic technique for intractable muscle atrophy by the xenotransplantation of neural stem cells derived from pig fetuses into peripheral nerves. In this study, we created a denervation model using neurotomy in nude rats and transplanted pig-fetus-derived neural stem cells into the cut nerve stump. Three months after transplantation, the survival of neural cells, the number and area of regenerated axons, and the degree of functional recovery by electrical stimulation of peripheral nerves were compared among the gestational ages (E 22, E 27, E 45) of the pigs. Transplanted neural cells were engrafted at all ages. Functional recovery by electric stimulation was observed at age E 22 and E 27. This study shows that the xenotransplantation of fetal porcine neural stem cells can restore denervated muscle function. When combined with medical engineering, this technology can help in developing a new therapy for paralysis.

1 July 2024 in JBJS Open Access
Verified
Journal Article
Open access
YTYu Takahashi
Yu Takahashi
YTYasuhiko Takegami
Yasuhiko Takegami
KTKatsuhiro Tokutake
Katsuhiro Tokutake
YAYuta Asami
Yuta Asami
HTHidetane Takahashi
Hidetane Takahashi
SIShiro Imagama
Shiro Imagama
Background: Calcaneal avulsion fractures (CAvFs) at the Achilles tendon insertion are among the more challenging fractures to treat. Although rare, they often require reoperation. The optimal treatment, including nonsurgical procedures and better implants for surgical procedures in the treatment of CAvFs, remains to be established. Therefore, our study aimed to (1) perform a descriptive evaluation of CAvFs, including cases managed nonsurgically, and (2) assess surgical procedures, including the incidence of complications and reoperation for surgically treated CAvFs. Methods: In this multicenter retrospective study, we collected data of patients with CAvFs treated at 9 hospitals from 2012 to 2022. We performed a descriptive study of CAvFs and compared postoperative complications and reoperation rates for multiple surgical techniques and implants. The size of the bone fragments was quantified. Results: The data of 70 patients with CAvFs were analyzed; 20 patients were treated nonsurgically, and 50 were treated surgically. The mean age of patients was 68.5 years; 67% of the patients were female. Nineteen percent of the patients had diabetes, and 19% had osteoporosis. The incidence of postoperative complications was 30%, with infection in 14%, necrosis in 26%, and loss of reduction in 18%. The reoperation rate was 22%. Surgical techniques with use of cannulated cancellous screws were performed in 80% of the surgical cases. Cannulated cancellous screw (CCS) fixation alone resulted in a reoperation rate of 35%, whereas additional augmentation, including washers with CCS fixation, resulted in a reoperation rate of 10%. CCS fixation was successfully performed, although suture anchors were used in some cases with smaller fragments. Conclusions: CAvFs occurred more frequently in older women and had a high rate of postoperative complications. A combination of CCS with augmentation was more effective at reducing postoperative complications than CCS fixation alone, even when the bone fragment size was small. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

7 April 2024 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
YKYoshihiko Kimura
Yoshihiko Kimura
YAYuta Asami
Yuta Asami
KTKatsuhiro Tokutake
Katsuhiro Tokutake
YTYasuhiko Takegami
Yasuhiko Takegami
KOKazuma Oshima
Kazuma Oshima
SIShiro Imagama
Shiro Imagama